Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter...
63 insider purchases on record · latest filing 2026-01-23.
Insiders have also filed 136 sale transactions at MIRM.